International Journal of Immunology Research

Vol. 4, Issue 1, Part A (2022)

Vaccines for SARS-CoV-2: How have they changed the landscape of COVID-19 pandemic

Author(s):

Dr. Supriya Shrivastava

Abstract:

COVID-19 pandemic has brought about huge disruptions to our lives. COVID-19 vaccines have been developed and manufactured in a record timeframe. The use of COVID-19 vaccines has mitigated morbidity and mortality associated with COVID-19 to a large extent. This happened because these vaccines have been able to elicit immune memory and longstanding cell-mediated immunity in vaccinated individuals. Vaccine hesitancy and unequitable distribution of vaccines have been the two stumbling blocks to widespread vaccination of populations. As SARS-CoV-2 seems to enter endemic phase, there is need for vaccines administered through respiratory route, which hopefully would elicit mucosal immunity and sterilizing immunity eventually stopping interhuman transmission of the virus.

Pages: 9-13  |  138 Views  45 Downloads

How to cite this article:
Dr. Supriya Shrivastava. Vaccines for SARS-CoV-2: How have they changed the landscape of COVID-19 pandemic. Int. J. Immunol. Res. 2022;4(1):9-13. DOI: 10.33545/26648865.2022.v4.i1a.10
Call for book chapter